ArticleRevista da Escola de Enfermagem da U S P2026
Seroprevalence of markers and immunization for hepatitis B in community health workers: a scoping review.
Article in Revista da Escola de Enfermagem da U S P, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Trends in hepatitis B virus seroprevalence in a large cohort of adult cancer patients from 2010 to 2023.Cancer causes & control : CCC · 2026Article
- Seroprevalence of markers and immunization for hepatitis B in community health workers: a scoping review.Revista da Escola de Enfermagem da U S P · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo map the scientific evidence concerning the prevalence of hepatitis B virus (HBV) and immunization among Community Health Workers (CHWs) worldwide.
methodA scoping review was conducted using the LILACS, Medline (via PubMed), Embase, and Scopus databases, as well as grey literature (Google Scholar, Pro-Quest), employing the recommendations of PRISMA-ScR (extension for scoping review) and the Joanna Briggs Institute Manual.
resultsEleven studies were included, all conducted in Brazil and without parameterization of the outcome measure. The estimated prevalence of HBV infection ranged from 8.2% to 11.1%, while vaccination coverage varied between 41% and 88.8%. Only one study used the anti-HBs serological marker to assess immunization, estimating that 71.6% of community health workers were immunized. Two additional studies were based on self-reported anti-HBs, with prevalences of 30.0% and 30.2%.
conclusionThe overall estimate of HBV infection prevalence and immunization among community health workers could not be determined due to the scarcity and geographical limitations of existing studies, as well as the measurements deparameterization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.